Surandy70 @surandy70.bsky.social · 24/02/2026Phase 1 due to commence March 16th. $NX1 #PanicDisorder 022
Surandy70 @surandy70.bsky.social · 30/09/2025$KPO via their transfer agreement should be getting a significant amount of funds very shortly with AESO DTS contracts due to be executed by the end of this week. 040
Surandy70 @surandy70.bsky.social · 15/09/2025In addition to advancing its two core ventures — Stealth Technologies (EdgeiQ) and Australian Advanced Materials (Energy Ink™) — Strategic Elements is actively scouting new opportunities across Australia’s innovation ecosystem. $SOR @asxsor 060
Surandy70 @surandy70.bsky.social · 21/08/2025Lumos Diagnostic submitted their CLIA waiver application for their already approved FebriDx point of care test on 15/8/2025. Approval is expected by mid-September, every chance it will be much earlier than that. $LDX #AMR 190
Surandy70 @surandy70.bsky.social · 07/08/2025$IRX gearing up to commence Phase 1 trial of their breakthrough cancer pain treatment and soon after, Phase 1 trial of their panic disorder treatment. 020